These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24649444)

  • 1. New and emerging treatments for epilepsy: review of clinical studies of lacosamide, eslicarbazepine acetate, ezogabine, rufinamide, perampanel, and electrical stimulation therapy.
    Chung SS; Kelly K; Schusse C
    J Epilepsy Res; 2011 Dec; 1(2):35-46. PubMed ID: 24649444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel medications for epilepsy.
    Fattore C; Perucca E
    Drugs; 2011 Nov; 71(16):2151-78. PubMed ID: 22035515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate.
    Patsalos PN; Berry DJ
    Expert Opin Pharmacother; 2012 Apr; 13(5):699-715. PubMed ID: 22404663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug interactions with the newer antiepileptic drugs (AEDs)--part 1: pharmacokinetic and pharmacodynamic interactions between AEDs.
    Patsalos PN
    Clin Pharmacokinet; 2013 Nov; 52(11):927-66. PubMed ID: 23784470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epilepsy: new drug targets and neurostimulation.
    Asconapé JJ
    Neurol Clin; 2013 Aug; 31(3):785-98. PubMed ID: 23896505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug interactions with the newer antiepileptic drugs (AEDs)--Part 2: pharmacokinetic and pharmacodynamic interactions between AEDs and drugs used to treat non-epilepsy disorders.
    Patsalos PN
    Clin Pharmacokinet; 2013 Dec; 52(12):1045-61. PubMed ID: 23794036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy of epilepsy: newly approved and developmental agents.
    Stephen LJ; Brodie MJ
    CNS Drugs; 2011 Feb; 25(2):89-107. PubMed ID: 21254787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in anti-epileptic drug testing.
    Krasowski MD; McMillin GA
    Clin Chim Acta; 2014 Sep; 436():224-36. PubMed ID: 24925169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
    Kanner AM; Ashman E; Gloss D; Harden C; Bourgeois B; Bautista JF; Abou-Khalil B; Burakgazi-Dalkilic E; Llanas Park E; Stern J; Hirtz D; Nespeca M; Gidal B; Faught E; French J
    Neurology; 2018 Jul; 91(2):74-81. PubMed ID: 29898971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical properties of antiepileptic drugs (AEDs).
    Bialer M
    Adv Drug Deliv Rev; 2012 Jul; 64(10):887-95. PubMed ID: 22210279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological management of epilepsy: recent advances and future prospects.
    Johannessen Landmark C; Johannessen SI
    Drugs; 2008; 68(14):1925-39. PubMed ID: 18778117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
    Kanner AM; Ashman E; Gloss D; Harden C; Bourgeois B; Bautista JF; Abou-Khalil B; Burakgazi-Dalkilic E; Llanas Park E; Stern J; Hirtz D; Nespeca M; Gidal B; Faught E; French J
    Neurology; 2018 Jul; 91(2):82-90. PubMed ID: 29898974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intractable Generalized Epilepsy: Therapeutic Approaches.
    Hwang ST; Stevens SJ; Fu AX; Proteasa SV
    Curr Neurol Neurosci Rep; 2019 Feb; 19(4):16. PubMed ID: 30806817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug interactions involving the new second- and third-generation antiepileptic drugs.
    Johannessen Landmark C; Patsalos PN
    Expert Rev Neurother; 2010 Jan; 10(1):119-40. PubMed ID: 20021326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Third-Generation Antiseizure Medication in the Treatment of Benzodiazepine-Refractory Status Epilepticus in Poststroke Epilepsy: A Retrospective Observational Register-Based Study.
    Winter Y; Sandner K; Vieth T; Gonzalez-Escamilla G; Stuckrad-Barre SV; Groppa S
    CNS Drugs; 2023 Oct; 37(10):929-936. PubMed ID: 37784006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rufinamide add-on therapy for refractory epilepsy.
    Panebianco M; Prabhakar H; Marson AG
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011772. PubMed ID: 29691835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing use of novel anti-epileptic drugs: is earlier better?
    de Biase S; Nilo A; Bernardini A; Gigli GL; Valente M; Merlino G
    Expert Rev Neurother; 2019 Oct; 19(10):945-954. PubMed ID: 31257949
    [No Abstract]   [Full Text] [Related]  

  • 18. New and forthcoming anti-epileptic drugs.
    Prunetti P; Perucca E
    Curr Opin Neurol; 2011 Apr; 24(2):159-64. PubMed ID: 21301338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent and future antiepileptic drugs and their impact on cognition: what can we expect?
    Mula M
    Expert Rev Neurother; 2012 Jun; 12(6):667-71. PubMed ID: 22650169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: Results of an indirect comparison meta-analysis of RCTs.
    Brigo F; Bragazzi NL; Nardone R; Trinka E
    Seizure; 2016 Nov; 42():29-37. PubMed ID: 27710868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.